Everything below concerns GW501516. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.
Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.
Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a metabolic modulator. |
| Approved medical use | None in major jurisdictions | Not a registered drug. |
| Common test matrix | Urine | Most anti-doping samples use urine. |
| Typical detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Reference standard storage | -20 °C, desiccated | Typical for analytical standards. |
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
The pharmacological interest in cardarine centers on PPARδ activation and its downstream effects on lipid handling and mitochondrial function. In animal studies, PPARδ agonists have been associated with changes in exercise endurance and fatty acid utilization, though results vary by model and protocol. Human data remain sparse, and the absence of large controlled trials limits conclusions about efficacy. Researchers often describe the compound as a tool for probing PPARδ biology rather than a proven therapeutic agent.
Safety discussions about cardarine frequently cite rodent carcinogenicity findings reported in the 2000s. In those studies, treated animals developed tumors at multiple sites, leading sponsors to discontinue clinical development. The relevance of these findings to humans has not been resolved, but they are a major reason the compound is not approved. Current literature emphasizes uncertainty about long-term effects and the risks of unregulated use. Regulators and health agencies have not established a safe human exposure level.
Cardarine is a synthetic compound also known as GW501516, GW-501516, and sometimes endurobol. It was developed as a selective agonist of peroxisome proliferator-activated receptor delta, a nuclear receptor involved in fatty acid oxidation and energy metabolism. The compound was studied in preclinical models for metabolic and cardiovascular conditions, but it did not become a marketed human medicine. In regulatory and anti-doping contexts, it is treated as a prohibited substance rather than a licensed medicine.
Another dye extracted from a related sea snail, Hexaplex trunculus, produced a blue colour after light exposure which could be the one known as tekhelet (תְּכֵלֶת), used in garments worn for ritual purposes.
== Normal ranges == The normal range of GFR, adjusted for body surface area, is 100–130 average 125 mL/min/1.73m2 in men and 90–120 mL/min/1.73m2 in women younger than the age of 40. In children, GFR measured by inulin clearance is 110 mL/min/1.73 m2 until 2 years of age in both sexes, and then it progressively decreases. After age 40, GFR decreases progressively with age, by 0.4–1.2 mL/min per year.
BASF announced that the transaction would allow the company to focus on its chemical and refinery catalysts business. Since 2016, BASF has partnered with a subsidiary of Xinjiang Zhongtai Group, a company sanctioned under the Uyghur Forced Labor Prevention Act, to operate a plant in Korla. In October 2017, BASF announced it would buy seed and herbicide businesses from Bayer for €5.9 billion ($7 billion), as part of Bayer's acquisition of Monsanto. The company announced the start of a US$10 billion investment project in the south-western Chinese city of Zhanjiang, in November 2019. The project was approved in 2022. This ″Verbund″ site is intended for the production of engineering plastics and TPU. The site would be the third-largest BASF site worldwide, following Ludwigshafen, Germany, and Antwerp, Belgium. The first plant started up in 2022, and the entire site is expected to be completed by 2030.
== Etymology == The word ant and the archaic word emmet are derived from ante, emete of Middle English, which come from ǣmette of Old English; these are all related to Low Saxon e(e)mt, empe and varieties (Old Saxon emeta) and to German Ameise (Old High German āmeiza). All of these words come from West Germanic *ǣmaitjōn, and the original meaning of the word was "the biter" (from Proto-Germanic *ai-, "off, away" + *mait- "cut"). The study of ants is called myrmecology, from Ancient Greek μύρμηξ mýrmēx ("ant"). It has been hypothesised that a Proto-Indo-European word *morwi- was the root for Sanskrit vamrah, Greek μύρμηξ mýrmēx, Latin formīca, Old Church Slavonic mraviji, Old Irish moirb, Old Norse maurr, Dutch mier, Swedish myra, Danish myre, Middle Dutch miere, and Crimean Gothic miera.
Sources: en.wikipedia.org
or the ratio of the thickness of the interfacial layer to the particle size. This model was shown to be more in agreement with the experimental results, but is limited in its applicability for there is not yet a theoretical way to establish the thermal conductivity, or the thickness of this layer.
In 2008, she portrayed an embattled guidance counselor in the gay-themed mystery film On the Other Hand, Death, and a supporting role as Laurie Strode's therapist, in Rob Zombie's Halloween II (2009). In an interview with the LGBT publication The Advocate, Kidder discussed her later career choices: "I'm not choosy at all! I'll do practically anything. I'm the biggest whore on the block. I live in a little town in Montana, and you have to drag me out of here to get to LA, so I'm not readily available. But unless it's something sexist or cruel, I just love to work. I've done all sorts of things, but you just haven't seen them because they're often very bad and shown at four in the morning." In 2015, Kidder won an Emmy Award for Outstanding Performer in Children's Programming for her performance in R.L. Stine's The Haunting Hour. She will appear posthumously in the psychological thriller Robber's Roost, directed by Galen Rosenthal, which will be her final film role.
Screens at Beirut–Rafic Hariri International Airport were hacked allegedly by the Christian group Jnud al-Rab to display an anti-Hezbollah message. Jnud al-Rab denied any involvement. On 28 January 2024, Bechara Boutros al-Rahi, Maronite Patriarch and head of the Maronite Church, stated that residents of southern Lebanon refuse to be used as "sacrificial lambs" in what he described as a "culture of death", implicitly referencing Hezbollah's border activities. He described the hardships faced by the people, including psychological strain and disrupted education for children, and said they refuse to be hostages or human shields. On 24 March 2024, a video showed a nun at a Lebanese Christian school asking students to pray for Hezbollah men defending Lebanon. The video went viral, with some praising the video and others criticizing it. Palestinians in Shatila refugee camp told Al Jazeera that they would fight on the side of Hezbollah and the Axis of Resistance in a war against Israel, but worried for their families and civilians as they feared that Israel would deliberately target densely populated civilian areas.
All meitnerium isotopes are extremely unstable (radioactive); in general, heavier isotopes are more stable than the lighter. The most stable known isotope, 278Mt (half-life 4.5 seconds), is also the heaviest known. The unconfirmed 282Mt is even heavier and seems to have a longer half-life, 67 seconds. With a half-life of 0.8 seconds, the next most stable known isotope is 270Mt. 276Mt and 274Mt have half-lives of 0.62 and 0.64 seconds respectively. 277Mt, created as the final decay product of 293Ts for the first time in 2012, was observed to undergo spontaneous fission, half-life 5 milliseconds. Preliminary data analysis considered the possibility that this fission is instead from 277Hs, for it also has a half-life of a few milliseconds, and could come from undetected electron capture somewhere in the decay chain. This possibility was later deemed very unlikely based on observed decay energies of 281Ds and 281Rg and the short half-life of 277Mt, although there is still some uncertainty of the assignment. Regardless, the rapid fission of 277Mt and 277Hs is strongly suggestive of a region of instability for superheavy nuclei with N = 168–170. The existence of this region, characterized by a decrease in fission barrier height between the deformed shell closure at N = 162 and spherical shell closure at N = 184, is consistent with theoretical models.
In the second half of 1945, Thomas began reading for the BBC Radio programme, Book of Verse, broadcast weekly to the Far East. This provided Thomas with a regular income and brought him into contact with Louis MacNeice, a congenial drinking companion whose advice Thomas cherished. On 29 September 1946, the BBC began transmitting the Third Programme, a high-culture network which provided opportunities for Thomas. He appeared in the play Comus for the Third Programme, the day after the network launched, and his rich, sonorous voice led to character parts, including the lead in Aeschylus's Agamemnon and Satan in an adaptation of Paradise Lost. Thomas remained a popular guest on radio talk shows for the BBC, who regarded him as "useful should a younger generation poet be needed". He had an uneasy relationship with BBC management and a staff job was never an option, with drinking cited as the problem. Despite this, Thomas became a familiar radio voice and within Britain was "in every sense a celebrity". The publication of Deaths and Entrances in February 1946 was a major turning point for Thomas. Poet and critic Walter J. Turner commented in The Spectator, "This book alone, in my opinion, ranks him as a major poet".
Sources: en.wikipedia.org
For the following year, Ubayd Allah was bogged down in battles with the Qaysi tribes of Jazira led by Zufar ibn al-Harith al-Kilabi. By 686, Ubayd Allah's army numbered some 60,000 troops. By the time Ubayd Allah's army approached Mosul toward Iraq, the Zubayrids under Mus'ab ibn al-Zubayr had established themselves in Basra while al-Mukhtar ibn Abi Ubayd took control of Kufa in the name of the Alid Muhammad ibn al-Hanafiyya. Al-Mukhtar dispatched Ibrahim ibn al-Ashtar and an army composed largely of non-Arab freedmen to confront Ubayd Allah. The latter fended off the first wave of al-Mukhtar's troops, and proceeded to face off Ibn al-Ashtar at the Khazir River. In the ensuing Battle of Khazir, the Umayyad army was routed and Ubayd Allah was slain by Ibn al-Ashtar. His lieutenants Husayn, Shurahbil and al-Rabi'a were also killed. With Ubayd Allah's death, Caliph Abd al-Malik halted further advances against Iraq until 691.
== External links == Wood Library-Museum of Anesthesiology The most comprehensive educational, scientific and archival resources in anesthesiology. "Chloroform: The molecular lifesaver" An article at University of Bristol providing interesting facts about chloroform. Australian & New Zealand College of Anaesthetists Monitoring Standard Royal College of Anaesthetists Patient Information page Turning the Pages: a virtual reconstruction of Hanaoka's Surgical Casebook, c. 1825. From the U.S. National Library of Medicine (in German) Die Geschichte der Anästhesie. "Anesthesia as a specialty: Past, present and future" Presentation by Prof. Janusz Andres.
In fact, the aggregation of a protein generates a variety of aggregates, all of which are likely to be toxic to some degree. A wide variety of biochemical, physiological and cytological perturbations has been identified following the exposure of cells and animals to such species, independently of their identity. The oligomers have also been reported to interact with a variety of molecular targets. Hence, it is unlikely that there is a unique mechanism of toxicity or a unique cascade of cellular events. The misfolded nature of protein aggregates causes a multitude of aberrant interactions with a multitude of cellular components, including membranes, protein receptors, soluble proteins, RNAs, small metabolites, etc.
Gopsill, Frank Peter; Sexton, Brian (2006) [2001]. "Le natura, si – un schema, no". Historia de interlingua (in Interlingua). Archived from the original on 2022-04-12. Retrieved 2025-01-14. Hill-Meyer, Tobi; Scarborough, Dean (2014). "Sexuality". In Erickson-Schroth, Laura (ed.). Trans Bodies, Trans Selves: A Resource for the Transgender Community (1st ed.). Oxford UP. ISBN 978-0-19-932535-1. OCLC 944726648. Houglum, Peggy A.; Bertoli, Dolores B. (2012). Brunnstrom's Clinical Kinesiology. F. A. Davis Company. ISBN 978-0-8036-2352-1. Janeway CA, Travers P, Walport M (2001). "Effector mechanisms in allergic reactions". Immunobiology (5th ed.). Garland Science. Janeway CA (2005). Immunobiology (6th ed.). Garland Science. ISBN 0-443-07310-4. Kendall, Florence Peterson; et al. (2005). Muscles : testing and function with posture and pain (5th ed.). Baltimore, MD: Lippincott Williams & Wilkins. ISBN 0-7817-4780-5. Knight, Sarah; Tilg, Stefan, eds. (2015). The Oxford Handbook of Neo-Latin. New York: Oxford University Press. ISBN 978-0-19-088699-8. OL 28648475M. Krishnaswamy G, Ajitawi O, Chi DS (2006). "The human mast cell: an overview". Mast Cells. Methods in Molecular Biology. Vol. 315. pp. 13–34. doi:10.1385/1-59259-967-2:013. ISBN 1-59259-967-2. PMID 16110146. McArthur, Tom (ed.): The Oxford Companion to the English Language, (Oxford University Press, 1992). ISBN 0-19-214183-X Murphy K, Weaver C (2016). Immunobiology (9 ed.). Garland Science. ISBN 978-0-8153-4505-3.
Their mass-to-charge ratio is proportional to their time of flight (TOF) in the drift tube and can be calculated accordingly. Coupling ESI with capillary LC can separate peptides from protein digests, while obtaining their molecular masses at the same time. Capillary electrophoresis coupled with ESI-MS is another technique; however, it works best when analyzing small amounts of proteins.
Sources: en.wikipedia.org
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.
Anti-doping laboratories use LC-MS/MS to detect GW501516 and its metabolites, usually in urine. The method can identify the parent compound at low concentrations. Detection windows vary with dose and individual factors.
No, cardarine has no approved medical uses in major jurisdictions. Early research explored metabolic conditions, but those programs were discontinued. It is not a registered treatment for any disease.
Anti-doping laboratories typically use LC-MS/MS to detect GW501516 and its metabolites in urine. The method is sensitive and can identify the compound at low concentrations. Detection depends on sample timing, metabolism, and the specific assay.